Brief: Impax Announces Sale Of Taiwan Manufacturing Facility

Bora Pharmaceuticals Co

19/12/2017 13:45

Dec 19 (Reuters) - Impax Laboratories Inc  IPXL.O : 
    * IMPAX ANNOUNCES SALE OF TAIWAN MANUFACTURING FACILITY 
    * IMPAX LABORATORIES INC -  ENTERED INTO A DEFINITIVE 
AGREEMENT 
TO SELL IMPAX TAIWAN TO BORA PHARMACEUTICALS CO 
    * IMPAX LABORATORIES - BORA WILL PURCHASE ALL OF ISSUED 
SHARE 
CAPITAL IN IMPAX TAIWAN, CERTAIN LOANS OUTSTANDING BETWEEN CO, 
UNIT FOR $18.5 MILLION. 
    * IMPAX LABORATORIES INC - AS A RESULT OF SALE, CO EXPECTS 
TO 
RECORD A PRE-TAX IMPAIRMENT CHARGE OF ABOUT $70.0 TO $80.0 
MILLION IN Q4 OF THIS YEAR 
    * IMPAX LABORATORIES INC - AS A RESULT OF SALE, CO EXPECTS 
TO 
RECORD PRE-TAX IMPAIRMENT CHARGE OF ABOUT $70.0 TO $80.0 MILLION 
IN Q4 OF THIS YEAR 
    * IMPAX LABORATORIES INC -  BORA WILL HAVE RIGHTS TO MARKET 
AND 
SELL IMPAX'S BRANDED PARKINSON'S DRUG RYTARY IN TAIWAN 
    * IMPAX - ALSO SIGNED SUPPLY AGREEMENT WITH BORA, EFFECTIVE 
UPON 
CLOSING OF TRANSACTION 
    * IMPAX SAYS SIGNED SUPPLY AGREEMENT WITH BORA TO 
MANUFACTURE, 
SUPPLY OF CERTAIN OF CO'S MARKETED, DEVELOPMENT PRODUCTS 
CURRENTLY MANUFACTURED BY UNIT 
 
Source text for Eikon:  ID:nPnmllTMa  
Further company coverage:  IPXL.O  
 
 ((bangalore.newsroom@thomsonreuters.com;))